Scott David Priebe

Array ( [id] => 6275823 [patent_doc_number] => 20020106650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Cystine-knot polypeptides: cloaked-2 molecules and uses thereof' [patent_app_type] => new [patent_app_number] => 09/867274 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32840 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106650.pdf [firstpage_image] =>[orig_patent_app_number] => 09867274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6944702 [patent_doc_number] => 20050196751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods' [patent_app_type] => utility [patent_app_number] => 09/861181 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11466 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196751.pdf [firstpage_image] =>[orig_patent_app_number] => 09861181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814102 [patent_doc_number] => 20030073652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Ex-vivo and in vivo factor XII gene therapy for hemophilia A and B' [patent_app_type] => new [patent_app_number] => 09/858909 [patent_app_country] => US [patent_app_date] => 2001-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7288 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073652.pdf [firstpage_image] =>[orig_patent_app_number] => 09858909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 990682 [patent_doc_number] => 06919208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-19 [patent_title] => 'Methods and compositions for enhancing the delivery of a nucleic acid to a cell' [patent_app_type] => utility [patent_app_number] => 09/851327 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 10588 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/919/06919208.pdf [firstpage_image] =>[orig_patent_app_number] => 09851327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1239510 [patent_doc_number] => 06686196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Recombinant, modified adenoviral vectors for tumor specific gene expression and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/849106 [patent_app_country] => US [patent_app_date] => 2001-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 32 [patent_no_of_words] => 16326 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686196.pdf [firstpage_image] =>[orig_patent_app_number] => 09849106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5803702 [patent_doc_number] => 20020010944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'CeSERT genes, proteins, and modulatory compounds' [patent_app_type] => new [patent_app_number] => 09/843598 [patent_app_country] => US [patent_app_date] => 2001-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19294 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010944.pdf [firstpage_image] =>[orig_patent_app_number] => 09843598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242087 [patent_doc_number] => 20020045173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'GLP-2 receptor gene promoter and uses thereof' [patent_app_type] => new [patent_app_number] => 09/833740 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13755 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045173.pdf [firstpage_image] =>[orig_patent_app_number] => 09833740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6789115 [patent_doc_number] => 20030140354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/820790 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20725 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20030140354.pdf [firstpage_image] =>[orig_patent_app_number] => 09820790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 687411 [patent_doc_number] => 07078584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'Salmonella typhimurium-infected Caenorhabditis elegans for identifying inhibitors of infection' [patent_app_type] => utility [patent_app_number] => 09/809773 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 26 [patent_no_of_words] => 10701 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078584.pdf [firstpage_image] =>[orig_patent_app_number] => 09809773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567785 [patent_doc_number] => 20020165173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'TCF responsive element' [patent_app_type] => new [patent_app_number] => 09/798128 [patent_app_country] => US [patent_app_date] => 2001-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 13076 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165173.pdf [firstpage_image] =>[orig_patent_app_number] => 09798128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223868 [patent_doc_number] => 20020004040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Complementary adenoviral vector systems and cell lines' [patent_app_type] => new [patent_app_number] => 09/797064 [patent_app_country] => US [patent_app_date] => 2001-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9781 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004040.pdf [firstpage_image] =>[orig_patent_app_number] => 09797064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908306 [patent_doc_number] => 20010011073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'Uses of transgenic animals containing a type X collagen mutant' [patent_app_type] => new [patent_app_number] => 09/794919 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10923 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011073.pdf [firstpage_image] =>[orig_patent_app_number] => 09794919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999246 [patent_doc_number] => 20020028193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Recombinant beta2-adrenergic receptor delivery and use in treating airway and vascular diseases' [patent_app_type] => new [patent_app_number] => 09/783580 [patent_app_country] => US [patent_app_date] => 2001-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24892 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028193.pdf [firstpage_image] =>[orig_patent_app_number] => 09783580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053100 [patent_doc_number] => 06858427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Sphingosine kinases' [patent_app_type] => utility [patent_app_number] => 09/784810 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 34637 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858427.pdf [firstpage_image] =>[orig_patent_app_number] => 09784810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356618 [patent_doc_number] => 20020058022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Novel compounds' [patent_app_type] => new [patent_app_number] => 09/772179 [patent_app_country] => US [patent_app_date] => 2001-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9425 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058022.pdf [firstpage_image] =>[orig_patent_app_number] => 09772179 [rel_patent_id] =>[rel_patent_doc_number] =>)